Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |